These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17207275)

  • 1. Effect of pioglitazone treatment on behavioral symptoms in autistic children.
    Boris M; Kaiser CC; Goldblatt A; Elice MW; Edelson SM; Adams JB; Feinstein DL
    J Neuroinflammation; 2007 Jan; 4():3. PubMed ID: 17207275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pioglitazone treatment in a patient with secondary multiple sclerosis.
    Pershadsingh HA; Heneka MT; Saini R; Amin NM; Broeske DJ; Feinstein DL
    J Neuroinflammation; 2004 Apr; 1(1):3. PubMed ID: 15285799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.
    Ghaleiha A; Rasa SM; Nikoo M; Farokhnia M; Mohammadi MR; Akhondzadeh S
    Psychiatry Res; 2015 Sep; 229(1-2):181-7. PubMed ID: 26208985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
    Akhondzadeh S; Fallah J; Mohammadi MR; Imani R; Mohammadi M; Salehi B; Ghanizadeh A; Raznahan M; Mohebbi-Rasa S; Rezazadeh SA; Forghani S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):32-6. PubMed ID: 19772883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
    Aman M; Rettiganti M; Nagaraja HN; Hollway JA; McCracken J; McDougle CJ; Tierney E; Scahill L; Arnold LE; Hellings J; Posey DJ; Swiezy NB; Ghuman J; Grados M; Shah B; Vitiello B
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):482-93. PubMed ID: 26262903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot dose finding study of pioglitazone in autistic children.
    Capano L; Dupuis A; Brian J; Mankad D; Genore L; Hastie Adams R; Smile S; Lui T; Odrobina D; Foster JA; Anagnostou E
    Mol Autism; 2018; 9():59. PubMed ID: 30498564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis.
    Kaiser CC; Shukla DK; Stebbins GT; Skias DD; Jeffery DR; Stefoski D; Katsamakis G; Feinstein DL
    J Neuroimmunol; 2009 Jun; 211(1-2):124-30. PubMed ID: 19446890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events.
    Starner CI; Schafer JA; Heaton AH; Gleason PP
    J Manag Care Pharm; 2008; 14(6):523-31. PubMed ID: 18693776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone abolishes autistic-like behaviors via the IL-6 pathway.
    Kirsten TB; Casarin RC; Bernardi MM; Felicio LF
    PLoS One; 2018; 13(5):e0197060. PubMed ID: 29791472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonidine treatment of hyperactive and impulsive children with autistic disorder.
    Jaselskis CA; Cook EH; Fletcher KE; Leventhal BL
    J Clin Psychopharmacol; 1992 Oct; 12(5):322-7. PubMed ID: 1479049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study.
    Capone GT; Goyal P; Grados M; Smith B; Kammann H
    J Dev Behav Pediatr; 2008 Apr; 29(2):106-16. PubMed ID: 18349709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications.
    Gagliano A; Germanò E; Pustorino G; Impallomeni C; D'Arrigo C; Calamoneri F; Spina E
    J Child Adolesc Psychopharmacol; 2004; 14(1):39-47. PubMed ID: 15142390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.
    Findling RL
    J Clin Psychiatry; 2005; 66 Suppl 10():26-31. PubMed ID: 16401147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine in the treatment of behavioral problems associated with autism: an open-label trial in Kuwait.
    Fido A; Al-Saad S
    Med Princ Pract; 2008; 17(5):415-8. PubMed ID: 18685284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder.
    Hardan AY; Handen BL
    J Child Adolesc Psychopharmacol; 2002; 12(3):237-41. PubMed ID: 12427297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.
    King BH; Wright DM; Handen BL; Sikich L; Zimmerman AW; McMahon W; Cantwell E; Davanzo PA; Dourish CT; Dykens EM; Hooper SR; Jaselskis CA; Leventhal BL; Levitt J; Lord C; Lubetsky MJ; Myers SM; Ozonoff S; Shah BG; Snape M; Shernoff EW; Williamson K; Cook EH
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):658-65. PubMed ID: 11392343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial.
    Fatemi SH; Realmuto GM; Khan L; Thuras P
    J Autism Dev Disord; 1998 Aug; 28(4):303-7. PubMed ID: 9711486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.
    Kalsekar I; Iyer S; Mody R; Rajagopalan R; Kavookjian J
    J Manag Care Pharm; 2006 Mar; 12(2):121-9. PubMed ID: 16515370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.